Skip to main content
Premium Trial:

Request an Annual Quote

ABI Launches Initiative to Support Third-Party Software Development for Next-Gen Sequencing

NEW YORK (GenomeWeb News) - Applied Biosystems said today that it has kicked off a program to help third-party software developers create bioinformatics tools for its SOLiD next-generation sequencing system.
ABI said it is expanding its Software Development Community to include sample data sets, data file formats, and data conversion tools for the SOLiD system. The company said that it has also “dedicated resources” to support bioinformatics developers that it expects to advance application development in several research areas, including whole-genome sequencing, chromatin immunoprecipitation, microbial sequencing, gene expression, microRNA discovery, digital karyotyping, epigenetic profiling, and detection of rare genetic variants.
ABI said it recently hosted a meeting for more than 40 researchers from 30 academic and commercial institutions “to provide input and share best practices with each other on their respective next-generation sequencing software development initiatives.”
Michael Wittig, a bioinformatician at the Institute for Clinical Molecular Biology in Kiel, Germany, said in a statement that the "promise that next-generation, genetic-analysis technologies will generate better data, faster, and at a lower cost will only be realized when there are sufficient software applications that allow researchers to analyze this data."
Darren Platt, head of informatics at the Department of Energy’s Joint Genome Institute, said the program "will enable us to rapidly develop the software applications our laboratories need to accelerate next-generation research projects."

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.